Fast Delivery

Safe and Secured Payments

Free Shipping on Orders Above 2000🎁

Mesacol Suppository 500mg

Mesalamine (5-ASA) for Ulcerative Proctitis & Distal Ulcerative Colitis | Strip of 7 Suppositories

130

Why Choose Arka Products

Quality Assurance

Clinically Proven

Transparent Ingredients

Customer Satisfaction

Mesacol Suppository contains mesalamine (5-aminosalicylic acid / 5-ASA), a well-established anti-inflammatory agent used in inflammatory bowel disease (IBD). Unlike oral therapies, this suppository delivers medication directly to the rectum and sigmoid colon, ensuring high local drug concentration where inflammation is most active.

It is particularly effective in patients with ulcerative proctitis and proctosigmoiditis, where disease involvement is limited to the distal colon. Mesalamine works by reducing inflammatory mediators in the colonic mucosa, helping relieve symptoms such as rectal bleeding, urgency, and discomfort.

Mesacol is commonly used both for inducing remission during flare-ups and for maintaining remission in chronic cases. It may also be prescribed alongside oral mesalamine for broader disease control.

Mesalamine (5-ASA) 500mg per suppository (confirm strength before publishing)

  • Delivers targeted anti-inflammatory action directly to the affected area
  • Helps reduce rectal bleeding, urgency, and inflammation
  • Promotes mucosal healing in distal ulcerative colitis
  • Minimal systemic absorption compared to oral therapies
  • Effective for both active disease management and maintenance therapy
  • Supports faster symptom relief in localized IBD
  • Use as prescribed by your doctor
  • Typically: Insert one suppository rectally once daily at bedtime
  • Empty bowels before use
  • Wash hands and unwrap the suppository
  • Lie on your side and gently insert the pointed end into the rectum
  • Remain lying down for 15–30 minutes after insertion
  • Do not swallow or chew
  • Store below 25°C; refrigerate briefly if softened
  • During flare-ups of ulcerative proctitis or distal ulcerative colitis
  • As maintenance therapy to prevent relapse
  • When prescribed alongside oral mesalamine for enhanced effect
  • Adults diagnosed with:
    • Ulcerative proctitis
    • Proctosigmoiditis
    • Distal ulcerative colitis
  • Patients prescribed rectal mesalamine by a qualified healthcare professional
  • Patients with allergy to mesalamine, salicylates, or sulfasalazine
  • Individuals with severe kidney or liver impairment
  • Children unless specifically prescribed
  • Pregnant or breastfeeding women without medical approval
  • Anyone not advised by a doctor to use rectal mesalamine

Related Products